Showing 1 of 1 recruiting trials for “Von Willebrand disease type 3”
Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
👨⚕️ Jonathan C Roberts, MD, Bleeding and Clotting Disorders Institute📍 9 sites📅 Started Nov 2022View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →